Business Context and Reporting Period
Company: Microbot Medical Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 8, 2025
Reporting Period: Event-based (July 8, 2025)
This filing serves as a Regulation FD disclosure regarding the company's participation in the inaugural Endovascular Robotics session at the Society of Robotic Surgery (SRS) annual meeting, scheduled for July 16-20, 2025, in Strasbourg, France.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on a specific corporate event and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The primary disclosure is the announcement of the company's upcoming participation in a significant industry conference.
Guidance, Outlook, and Management Commentary
- Event Participation: Microbot Medical Inc. will participate in the inaugural Endovascular Robotics session at the SRS annual meeting.
- Location and Date: Strasbourg, France, from July 16-20, 2025.
- Legal Disclaimer: The information furnished in this Item 7.01 and the accompanying press release (Exhibit 99.1) is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not an admission as to the materiality of the information.
Investor Verification Checklist
- Verify the content of the press release attached as Exhibit 99.1 for specific details on the company's presentation or product demonstrations at the SRS meeting.
- Confirm the company's stock trading symbol (MBOT) on the NASDAQ Capital Market.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial performance.